科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/06/13 | 3,715 | 3,780 | 3,715 | 3,760 | +35 | +0.9% | 69,200 |
| 2022/06/10 | 3,740 | 3,770 | 3,725 | 3,725 | -35 | -0.9% | 67,100 |
| 2022/06/09 | 3,755 | 3,810 | 3,750 | 3,760 | +15 | +0.4% | 60,500 |
| 2022/06/08 | 3,720 | 3,775 | 3,720 | 3,745 | +45 | +1.2% | 63,200 |
| 2022/06/07 | 3,685 | 3,715 | 3,680 | 3,700 | +20 | +0.5% | 46,800 |
| 2022/06/06 | 3,670 | 3,710 | 3,670 | 3,680 | ±0 | ±0% | 58,200 |
| 2022/06/03 | 3,685 | 3,705 | 3,675 | 3,680 | +25 | +0.7% | 66,600 |
| 2022/06/02 | 3,680 | 3,680 | 3,635 | 3,655 | -25 | -0.7% | 43,100 |
| 2022/06/01 | 3,625 | 3,705 | 3,625 | 3,680 | +80 | +2.2% | 70,700 |
| 2022/05/31 | 3,655 | 3,690 | 3,600 | 3,600 | -40 | -1.1% | 98,900 |
| 2022/05/30 | 3,615 | 3,670 | 3,600 | 3,640 | +60 | +1.7% | 128,400 |
| 2022/05/27 | 3,580 | 3,605 | 3,545 | 3,580 | +5 | +0.1% | 77,200 |
| 2022/05/26 | 3,555 | 3,595 | 3,555 | 3,575 | +5 | +0.1% | 61,800 |
| 2022/05/25 | 3,585 | 3,620 | 3,570 | 3,570 | -25 | -0.7% | 87,400 |
| 2022/05/24 | 3,650 | 3,650 | 3,590 | 3,595 | -70 | -1.9% | 41,900 |
| 2022/05/23 | 3,620 | 3,680 | 3,605 | 3,665 | +80 | +2.2% | 78,700 |
| 2022/05/20 | 3,655 | 3,655 | 3,580 | 3,585 | -55 | -1.5% | 104,900 |
| 2022/05/19 | 3,610 | 3,660 | 3,610 | 3,640 | -90 | -2.4% | 62,700 |
| 2022/05/18 | 3,735 | 3,750 | 3,710 | 3,730 | -15 | -0.4% | 55,600 |
| 2022/05/17 | 3,765 | 3,805 | 3,745 | 3,745 | +10 | +0.3% | 40,300 |
| 2022/05/16 | 3,840 | 3,840 | 3,730 | 3,735 | -70 | -1.8% | 59,300 |
| 2022/05/13 | 3,725 | 3,805 | 3,680 | 3,805 | +75 | +2% | 66,900 |
| 2022/05/12 | 3,845 | 3,845 | 3,730 | 3,730 | -125 | -3.2% | 99,800 |
| 2022/05/11 | 3,930 | 3,975 | 3,815 | 3,855 | -80 | -2% | 117,000 |
| 2022/05/10 | 3,955 | 3,970 | 3,925 | 3,935 | -5 | -0.1% | 76,400 |
| 2022/05/09 | 3,965 | 3,980 | 3,930 | 3,940 | -30 | -0.8% | 69,100 |
| 2022/05/06 | 3,950 | 3,990 | 3,925 | 3,970 | +20 | +0.5% | 75,400 |
| 2022/05/02 | 3,935 | 3,970 | 3,915 | 3,950 | +15 | +0.4% | 51,800 |
| 2022/04/28 | 3,825 | 3,945 | 3,810 | 3,935 | +125 | +3.3% | 94,900 |
| 2022/04/27 | 3,830 | 3,850 | 3,785 | 3,810 | -40 | -1% | 132,100 |
| 2022/04/26 | 3,860 | 3,885 | 3,845 | 3,850 | ±0 | ±0% | 58,800 |
| 2022/04/25 | 3,835 | 3,865 | 3,820 | 3,850 | -15 | -0.4% | 63,900 |
| 2022/04/22 | 3,845 | 3,880 | 3,840 | 3,865 | -10 | -0.3% | 43,300 |
| 2022/04/21 | 3,850 | 3,890 | 3,850 | 3,875 | +55 | +1.4% | 54,700 |
| 2022/04/20 | 3,820 | 3,835 | 3,790 | 3,820 | +15 | +0.4% | 60,600 |
| 2022/04/19 | 3,810 | 3,815 | 3,775 | 3,805 | +10 | +0.3% | 63,800 |
| 2022/04/18 | 3,800 | 3,805 | 3,760 | 3,795 | -30 | -0.8% | 107,900 |
| 2022/04/15 | 3,870 | 3,885 | 3,815 | 3,825 | -70 | -1.8% | 83,900 |
| 2022/04/14 | 3,880 | 3,905 | 3,875 | 3,895 | ±0 | ±0% | 58,100 |
| 2022/04/13 | 3,895 | 3,915 | 3,870 | 3,895 | ±0 | ±0% | 64,600 |
| 2022/04/12 | 3,945 | 3,950 | 3,895 | 3,895 | -40 | -1% | 68,200 |
| 2022/04/11 | 3,930 | 3,950 | 3,910 | 3,935 | ±0 | ±0% | 79,200 |
| 2022/04/08 | 3,985 | 3,990 | 3,910 | 3,935 | +5 | +0.1% | 93,600 |
| 2022/04/07 | 3,890 | 3,945 | 3,870 | 3,930 | +30 | +0.8% | 124,500 |
| 2022/04/06 | 3,945 | 3,955 | 3,885 | 3,900 | -25 | -0.6% | 148,800 |
| 2022/04/05 | 3,975 | 3,975 | 3,915 | 3,925 | ±0 | ±0% | 67,300 |
| 2022/04/04 | 3,955 | 3,955 | 3,920 | 3,925 | +10 | +0.3% | 52,700 |
| 2022/04/01 | 3,890 | 3,935 | 3,870 | 3,915 | +25 | +0.6% | 106,700 |
| 2022/03/31 | 3,935 | 3,945 | 3,880 | 3,890 | -55 | -1.4% | 130,900 |
| 2022/03/30 | 3,945 | 3,965 | 3,900 | 3,945 | -120 | -3% | 181,400 |
701～
750
件表示中 / 3684件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 410,900円 | +30.5% | +111.0% | 4.62% | 11.58倍 | 1.01倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 住友ファーマ | 62,700円 | +21.1% | - | 0.00% | 15.57倍 | 2.18倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ペプチド | 187,600円 | +5.0% | +1.5% | 0.00% | 16.10倍 | 4.28倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 378,000円 | +14.5% | -2.3% | 2.38% | 13.83倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| サンバイオ | 227,800円 | - | - | 0.00% | - | 105.51倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
